Applications of tissue microarray technology in immunohistochemistry: A study on c-kit expression in small cell lung cancer

Human Pathology

Volumn 35, Issue 11, 2004, Pages 1347-1352

  Donati, Valentina ^a   Faviana, Pinuccia ^a   Dell'Omodarme, Matteo ^a   Prati, Maria Cristina ^a   Camacci, Tiziano ^a   De Ieso, Katia ^a   Giannini, Riccardo ^a   Lucchi, Marco ^a   Mussi, Alfredo ^a   Pingitore, Raffaele ^a   Basolo, Fulvio ^a   Fontanini, Gabriella ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

c kit; IHC; immunohistochemistry; SCF; SCLC; small cell lung cancer; stem cell factor; tissue microarray; TMA; whole tissue section; WS

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; TREATMENT PLANNING;

ADULT; AGED; CARCINOMA, SMALL CELL; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-KIT; REPRODUCIBILITY OF RESULTS;

EID: 10044281355     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.07.016     Document Type: Article

References (34)

1. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 4:1998;844-847
2. Bubendorf L., Kolmer M., Kononen J., et al. Hormone therapy failure in human prostate cancer Analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst. 91:1999;1758-1764
3. Moch H., Schraml P., Bubendorf L., et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol. 154:1999;981-986
4. Mucci N.R., Akdas G., Manely S., et al. Neuroendocrine expression in metastatic prostate cancer Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol. 31:2000;406-414
5. Camp R.L., Charette L.A., Rimm D.L. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 80:2000;1943-1949
6. Mills S.E., Fechner R.E., Frierson H.F., et al. Guardians of the wax and the patient. Am J Clin Pathol. 110:1995;758-764
7. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep. 4:1973;31-42
8. Albain K.S., Crowley J.J., Livingston R.B. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Chest. 99:1991;1425-1432
9. Sørensen J.B., Østerlind K. Prognostic factors From clinical parameters to new biological markers. Van Houtte P., Klastersky J., Rocmans P. Progress and Perspectives in the Treatment of Lung Cancer. 1999;1-21 Springer, Berlin
10. Salgia R., Skarin A.T. Molecular abnormalities in lung cancer. J Clin Oncol. 16:1998;1207-1217
11. Rozengurt E. Autocrine loops, signal transduction, and cell cycle abnormalities in the molecular biology of lung cancer. Curr Opin Oncol. 11:1999;116-122
12. Ashman L.K. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol. 31:1999;1037-1051
13. Maeda H., Yamagata A., Nishikawa S., et al. Requirement of c-kit for development of intestinal pacemaker system. Development. 116:1992;369-375
14. Tsuura Y., Hiraki H., Watanabe K., et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch. 424:1994;135-141
15. Sanders K.M. A case for interstitial cells as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology. 111:1996;492-515
16. Natali P.G., Nicotra M.R., Sures I., et al. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res. 52:1992;6139-6143
17. Heinrich M., Blanke C., Druker B., et al. Inhibition of KIT tyrosine kinase activity A novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol. 20:2002;1692-1703
18. Ricotti E., Fagioli F., Garelli E., et al. C-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. Blood. 91:1998;2397-2405
19. Micke P., Basrai M., Faldum A., et al. Characterization of c-kit expression in small cell lung cancer Prognostic and therapeutic implications. Clin Cancer Res. 9:2003;188-194
20. Armitage P., Berry G., Matthews J.N.S. Statistical Methods in Medical Research. 4th ed. :2002;Blackwell, New York
21. Ihaka R., Gentleman R. A language for data analysis and graphics. J Comput Graphical Stat. 5:1996;299-314
22. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 2000;Wiley, New York
23. Zhang D., Salto-Tellez M., Do E., et al. Evaluation of HER-2/neu oncogene status in breast tumours on tissue microarrays. Hum Pathol. 34:2003;362-368
24. Zhang D., Salto-Tellez M., Putti T.C., et al. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol. 16:2003;79-85
25. O'Grady A., Flahavan C.M., Kay E.W., et al. HER-2 analysis in tissue microarrays of archival human breast cancer Comparison of immunohistochemistry and fluorescence in situ hybridisation. Appl Immunohistochem Mol Morphol. 11:2003;177-182
26. Hoos A., Urist M.J., Stojadinovic A., et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol. 158:2001;1245-1251
27. Gulmann C., Butler D., Kay E., et al. Biopsy of a biopsy Validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology. 42:2003;70-76
28. Jourdan F., Sebbagh N., Comperat E., et al. Tissue microarray technology Validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch. 443:2003;115-121
29. Gillett C.E., Springall R.J., Barnes D.M., et al. Multiple tissue core arrays in histopathology research A validation study. J Pathol. 192:2000;549-553
30. Krystal G.W., Hines S.J., Organ C.P. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res. 56:1996;370-376
31. Hibi K., Takahashi T., Sekido Y., et al. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene. 6:1991;2291-2296
32. Sekido Y., Obata Y., Ueda R., et al. Preferential expression of c-kit protooncogene transcripts in small cell lung cancer. Cancer Res. 51:1991;2416-2419
33. Papadimitriou C.A., Topp M.S., Serve H., et al. Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines. Eur J Cancer. 31:1995;2371-2378
34. Rygaard K., Nakamura T., Spang-Thomsen M. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer. 67:1993;37-46